Health & Tech

Mindset Pharma to be Acquired by Otsuka Pharmaceutical

Capital 10X Interview Series | Mindset Pharma: Leaders in Next-Gen Psychedelics

Mindset Pharma: New Study Supports Non-Hallucinogenic Psychedelics

Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds

Ricebran Technologies (RIBT) – Expansion and Grain Industry Tailwinds

Capital 10X Growth Navigator – February 1st 2022

Growth Navigator: Psilocybin Exports, Cannabis ESG & SAFE

Growth Navigator: Cannabis, Copper & Psychedelics

Pfizer Takes the Lead, as the World Moves Closer to A Viable Vaccine

Johnson & Johnson pushes the Pause Button on its COVID-19 Clinical Trial